Research programme : small molecule therapeutics - Axial Biotherapeutics
Alternative Names: AX-7000Latest Information Update: 10 May 2024
At a glance
- Originator Axial Therapeutics
- Class Antifibrotics; Hepatoprotectants; Small molecules
- Mechanism of Action Microbiome modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Fibrosis; Non-alcoholic steatohepatitis
Most Recent Events
- 18 Apr 2024 Early research in Fibrosis in USA (unspecified route) (Axial Therapeutics pipeline, April 2024)
- 18 Apr 2024 Early research in Non-alcoholic steatohepatitis in USA (unspecified route) (Axial Therapeutics pipeline, April 2024)